The Pak4 protein kinase is required for oncogenic transformation of MDA-MB-231 breast cancer cells

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Wong, L E ^a   Chen, N ^b,c   Karantza, V ^b,c   Minden, A ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Acini; Breast cancer; Pak4; Tumorigenesis

Indexed keywords

BETA CATENIN; P21 ACTIVATED KINASE 4; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THREE DIMENSIONAL IMAGING; TUMOR XENOGRAFT;

MUS; MUS MUSCULUS;

EID: 84879909485     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.13     Document Type: Article

References (25)

1. Eswaran J, Soundararajan M, Kumar R, Knapp S. UnPAKing the class differences among p21-activated kinases. Trends Biochem Sci 2008; 33: 394-403.
2. Wells CM, Jones GE. The emerging importance of group II PAKs. Biochem J 2010; 425: 465-473.
3. Eswaran J, Soundararajan M, Knapp S. Targeting group II Paks in cancer and metastasis. Cancer Metastasis Rev 2009; 28: 209-217.
4. Liu Y, Xiao H, Tian Y, Nekrasova T, Hao X, Lee HJ et al. The Pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol Cancer Res 2008; 6: 1215-1224.
5. Liu Y, Chen N, Cui X, Zheng X, Deng L, Price S et al. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene 2010; 29: 5883-5894.
6. Yu W, Kanaan Y, Bae YK, Gabrielson E. Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet Cytogenet 2009; 193: 29-37.
7. Rafn B, Nielsen CF, Andersen SH, Szyniarowski P, Corcelle-Termeau E, Valo E et al. ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression. Mol Cell 2012; 45: 764-776.
8. So JY, Lee HJ, Kramata P, Minden A, Suh N.. Differential expression of key signaling proteins in MCF10 cell lines, a human breast cancer progression model. Mol Cell Pharmacol 2012; 4: 31-40.
9. Callow MG, Clairvoyant F, Zhu S, Schryver B, Whyte DB, Bischoff JR et al. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 2002; 277: 550-558. (Pubitemid 34952091)
10. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002; 111: 29-40.
11. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogeesis of MCF- 10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268. (Pubitemid 36677560)
12. Karantza-Wadsworth V, White E. A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression. Methods Enzymol 2008; 446: 61-76.
13. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21: 1621-1635. (Pubitemid 47026367)
14. Wang RA, Zhang H, Balasenthil S, Medina D, Kumar R. PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 2006; 25: 2931-2936. (Pubitemid 43739243)
15. Molli PR, Li D-Q, Brion M, Rayala SK, Kumar R. Pak signaling in oncogenesis. Oncogene 2009; 28: 2545-2555.
16. Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer 2006; 6: 459-471.
17. Dummler B, Ohshiro K, Kumar R, Field J. Pak protein kinases and their role in cancer. Cancer Metastasis Rev 2009; 28: 51-63.
18. Friedland JC, Lakins JN, Kazanietz MG, Chernoff J, Boettiger D, Weaver VM. Alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NFkappaB- dependent resistance to apoptosis in 3D mammary acini. J Cell Sci 2007; 120(Pt 20): 3700-3712. (Pubitemid 350120961)
19. Arias-Romero LE, Villamar-Cruz O, Pacheco A, Kosoff R, Huang M, Muthuswamy SK et al. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Oncogene 2010; 29: 5839-5849.
20. Arias-Romero LE, Chernoff J. p21-activated kinases in Erbb-positive breast cancer: a new therapeutic target? Small GTPases 2010; 1: 124-128.
21. Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V et al. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 1998; 17: 6527-6540. (Pubitemid 28521788)
22. Gnesutta N, Minden A. Death receptor induced activation of initiator caspase-8 is antagonized by the serine/threonine kinase PAK4. Mol Cell Biol 2003; 23: 7838-7848. (Pubitemid 37271480)
23. Gnesutta N, Qu J, Minden A. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem 2001; 276: 14414-14419.
24. Li X, Minden A.. PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor. J Biol Chem 2005; 280: 41192-41200. (Pubitemid 41832173)
25. Wong LE, Reynolds AB, Dissanayaka NT, Minden A. p120-catenin is a binding partner and substrate for Group B Pak kinases. J Cell Biochem 2010; 110: 1244-1254.